Masashi Urabe Selected Research

Masashi Urabe Research Topics

Disease

12	Neoplasms (Cancer) 03/2019 - 01/2002
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 04/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2019 - 01/2002
3	Glioma (Gliomas) 01/2019 - 05/2009
2	Fibrosis (Cirrhosis) 11/2018 - 04/2008
2	Endometrial Neoplasms (Endometrial Cancer) 08/2013 - 12/2011
2	Lymphatic Metastasis 08/2013 - 12/2011
2	Phenylketonurias (Phenylketonuria) 01/2012 - 02/2011
2	Pulmonary Arterial Hypertension 09/2007 - 09/2007
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2004 - 01/2002
2	Heart Failure 05/2004 - 01/2002
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2018
1	Infarction (Infarctions) 12/2018
1	Lung Injury 11/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2018
1	Carcinogenesis 03/2018
1	Teratoma (Teratoid Tumor) 01/2018
1	Inflammation (Inflammations) 12/2015
1	Peritoneal Fibrosis 12/2015
1	Squamous Cell Carcinoma of Head and Neck 01/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2013
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Retinoblastoma (Glioblastoma, Retinal) 01/2013
1	Brain Neoplasms (Brain Tumor) 01/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2012
1	Uterine Neoplasms (Uterine Cancer) 12/2011
1	Parkinson Disease (Parkinson's Disease) 09/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2008
1	Body Weight (Weight, Body) 04/2008
1	Heart Diseases (Heart Disease) 04/2008
1	Hypertension (High Blood Pressure) 04/2008
1	Hypertrophy 04/2008
1	Disease Progression 01/2007
1	Ascites 04/2002
1	Ischemia 03/2002
1	Muscular Dystrophies (Muscular Dystrophy) 01/2002

Drug/Important Bio-Agent (IBA)

4	Interleukin-10 (Interleukin 10)IBA 11/2018 - 09/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 03/2002
4	Complementary DNA (cDNA)IBA 08/2013 - 01/2002
3	LuciferasesIBA 01/2013 - 05/2008
2	CytokinesIBA 03/2019 - 11/2018
2	alpha-hydroxyglutarateIBA 01/2019 - 01/2013
2	EnzymesIBA 01/2019 - 09/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019 - 01/2013
2	Vascular Endothelial Growth Factor CIBA 08/2013 - 12/2011
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2012 - 02/2011
2	MonocrotalineIBA 09/2007 - 09/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2007 - 04/2002
2	DystrophinIBA 05/2004 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 04/2002 - 01/2002
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cyclin B1IBA 01/2021
1	TubulinIBA 01/2021
1	tyrosyltubulin carboxypeptidaseIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 02/2019
1	Oncogene Proteins (Oncogene Protein)IBA 02/2019
1	Nucleic AcidsIBA 01/2019
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2019
1	Amino Acids FDA Link 01/2019
1	SurvivinIBA 12/2018
1	Green Fluorescent ProteinsIBA 12/2018
1	Neuroprotective AgentsIBA 12/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2018
1	Small Interfering RNA (siRNA)IBA 03/2018
1	Viral ProteinsIBA 03/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 12/2015
1	Galanin Receptors (Galanin Receptor)IBA 01/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2014
1	GalaninIBA 01/2014
1	Interleukin-2 (IL2)IBA 08/2013
1	Chimeric Antigen ReceptorsIBA 08/2013
1	Conditioned Culture MediaIBA 08/2013
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 08/2013
1	parthenolideIBA 01/2013
1	Retinoblastoma ProteinIBA 01/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2013
1	isocitric acid (isocitrate)IBA 01/2013
1	AminesIBA 01/2012
1	Phenylalanine (L-Phenylalanine)FDA Link 02/2011
1	Dopamine (Intropin)FDA LinkGeneric 09/2010
1	Aromatic-L-Amino-Acid DecarboxylasesIBA 09/2010
1	Thymidine KinaseIBA 05/2009
1	Ganciclovir (Cytovene)FDA LinkGeneric 05/2009
1	Atrial Natriuretic Factor (ANF)IBA 04/2008
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 09/2007
1	prostacyclin synthetase (prostacyclin synthase)IBA 09/2007
1	Topoisomerase I InhibitorsIBA 05/2002
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2002
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 05/2002
1	Antineoplastic Agents (Antineoplastics)IBA 05/2002

Therapy/Procedure

5	Therapeutics 08/2013 - 05/2009
1	Transplantation 01/2018
1	Peritoneal Dialysis 12/2015
1	Immunomodulation 12/2015
1	Hematopoietic Stem Cell Transplantation 05/2008
1	Intramuscular Injections 09/2007
1	Catheters 09/2007